The Link Between Itch and Aging, with Daniel Butler, MD
Daniel Butler, MD, discusses a more complex definition of immunosenescence, and the interplay between aging and itch-related conditions.
Daniel Butler, MD, is associate professor of medicine at the College of Medicine Tucson, University of Arizona. He is also the Director of the Inflammatory & Aging Skin Research Program, and a pioneer in the space of geriatric dermatology.
Butler sat down with Patient Care Online© live at the 2025 American Academy of Dermatology Conference in Orlando, March 7-11, to discuss many issues related to chronic itch in older patients, including the concept of immunosenescence and why its more complex a process than generally understood, and how it relates to the interplay between aging and itch.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
